Drug Trial Radar · NCT06819735
Study of DT-7012 as a Single Agent and in Combination With an Immune Checkpoint Inhibitor in Participants With Advanced Solid Tumors
Last checked: Nov 19, 2026Latest source record: May 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
125
Planned (sponsor's estimate)
Start
Jun 25, 2025
Primary completion
Sep 2027
Study completion Jan 2028
Sponsor
- Lead sponsor
- Domain Therapeutics Australia Pty LtdIndustry
- Sponsor type
- Industry
- Collaborators
- Domain Therapeutics SA
- First posted
- Feb 11, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a phase 1/2, dose-escalation, clinical study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of DT-7012 (an anti-CCR8 monoclonal antibody) as a single agent and in combination with an immune checkpoint inhibitor in adult participants with selected advanced solid tumors.
Conditions
- Advanced Solid Tumors
Interventions
DT-7012Drug
Intravenous infusion
Immune checkpoint inhibitorDrug
Intravenous infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of participants with DLTs, TEAEs, TRAEs, AESIs, SAEs and AEs leading to treatment discontinuationTime frame: Cycle 1 (21 days)
Locations
9 sites in 3 countries. Site status is shown where the registry gives one.
Honor Health Research Institute
Scottsdale, Arizona · Not yet recruiting
Macquarie University Clinical Trial Unit
North Ryde, New South Wales, Australia · Recruiting
Cancer Research SA
Adelaide, South Australia, Australia · Recruiting
Peninsula & South Eastern Haematology & Oncology Group
Frankston, Victoria, Australia · Recruiting
Cabrini Health Limited
Malvern, Victoria, Australia · Recruiting
One Clinical Research Pty Ltd
Nedlands, Western Australia, Australia · Recruiting
Institut Bergonié
Bordeaux, France · Recruiting
Hôpitaux Universitaires de Strasbourg
Strasbourg, France · Recruiting
Institut Gustave Roussy
Villejuif, France · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.